Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2009-06-19
2011-12-20
Vivlemore, Tracy (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C514S04400A
Reexamination Certificate
active
08080651
ABSTRACT:
Polynucleotide and polypeptide sequences for HFE2A, as well as mutations associated with juvenile hemochromatosis, and methods of utilizing these for the screening and identification of agents for the treatment of diseases of iron metabolism, including small organic compounds, are disclosed along with methods of treating and/or ameliorating diseases of iron metabolism, especially in human patients are disclosed. Diagnostic compounds, kits and methods using HFE2A are also described.
REFERENCES:
patent: 6943241 (2005-09-01), Isogai et al.
patent: 7250496 (2007-07-01), Bentwich
patent: 7511018 (2009-03-01), Goldberg et al.
patent: 7534764 (2009-05-01), Ganz et al.
patent: 7696155 (2010-04-01), Woolf et al.
patent: 7696156 (2010-04-01), Woolf et al.
patent: 7745407 (2010-06-01), Ganz et al.
patent: 7893206 (2011-02-01), Goldberg et al.
patent: 2004/0102376 (2004-05-01), Mueller
patent: 2007/0004618 (2007-01-01), Ganz et al.
patent: WO 96/13518 (1996-05-01), None
patent: WO 9640162 (1996-12-01), None
patent: WO 00/73801 (2000-12-01), None
patent: WO 01/74901 (2001-10-01), None
patent: WO 02/051438 (2002-07-01), None
patent: WO 02/074961 (2002-09-01), None
patent: WO 2004/092405 (2004-10-01), None
Afanassiev et al., Mutation Research, vol. 464, pp. 297-308 (2000).
Collins et al., PNAS USA, vol. 99(26), pp. 16899-16903 (2002).
Goldberg et al., Amer. J. Human Gen., vol. 73, p. 205 (2003) (Abstract).
Gonzalez et al., Curr. Opin. Biotechnology, vol. 9, pp. 624-631 (1998).
Hertzberg et al., Curr. Op. Chem. Biol., vol. 4, pp. 445-451 (2000).
Koller et al., Trends in Pharmacol. Sci., vol. 21, pp. 142-148 (2000).
Leong and Lonnerdal, J. Nutrition, vol. 134, pp. 1-4 (2004).
Lin et al., Blood, vol. 106, pp. 2884-2889 (2005).
Mattheakis et al., Chem. & Biol., Curr. Biol., vol. 6, pp. 835-844 (1999).
Mueller, B.K., Ann. Rev. Neurosci., vol. 22, pp. 351-388 (1999).
Muller et al., Current Biology, vol. 6, pp. 1497-1502 (1996).
Pender et al., J. Med. Chem., vol. 44, pp. 36-45 (2001).
Taupin et al., J. Immun. Methods, vol. 256, pp. 77-87 (2001).
Ganz, T., J. Am. Soc. Nephrol., vol. 18, pp. 394-400 (2007).
Carella Byrne et al.
Grant Alan J.
Olstein Elliot M.
Vivlemore Tracy
Xenon Pharmaceuticals Inc.
LandOfFree
Juvenile hemochromatosis gene (HFE2A), expression products... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Juvenile hemochromatosis gene (HFE2A), expression products..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Juvenile hemochromatosis gene (HFE2A), expression products... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4262433